Janux Therapeutics, Inc. Profile Avatar - Palmy Investing

Janux Therapeutics, Inc.

Janux Therapeutics, Inc., a biopharmaceutical company, develops therapeutics based on proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to treat patients suffering from cancer. The company's lead TRACTr product candidates that are i…

Biotechnology
US, La Jolla [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

Janux Therapeutics, Inc. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

Janux Therapeutics, Inc. can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of Janux Therapeutics, Inc..

End of JANX's Analysis
CIK: 1817713 CUSIP: 47103J105 ISIN: US47103J1051 LEI: - UEI: -
Secondary Listings
JANX has no secondary listings inside our databases.